The pricing agreement in Regeneron Pharmaceuticals, Inc. ’s COVID-19 deal with the US Biomedical Advanced Research and Development Authority (BARDA) is not groundbreaking, even though it jarred loose
Herbalife Distributor Leaves Board To Become Strategy Chief Health and wellness products direct seller Herbalife Nutrition Ltd. . appoints Stephan Gratziani, an independent distributor with business
The market for initial public offerings by biopharmaceutical companies declined to just 22 IPOs in the US in 2022 and it has gotten off to a slow start in 2023 with just three small offerings to date,
Development setbacks continue for Inovio Pharmaceuticals, Inc. as the Philadelphia-area firm revealed on 17 November that it is ending development of a pair of vaccine candidates – INO-4500 for Lass